Key Financial Data Of Reporting Company

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7539811

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-01-01 to
2023-09-30
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-07-01 to
2022-09-30
As at
2022-09-30
2022-01-01 to
2022-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
119,115,000,000 JPY
166,258,000,000 JPY
114,279,000,000 JPY
Ordinary profit (loss)
20,837,000,000 JPY
28,281,000,000 JPY
20,433,000,000 JPY
Net assets
214,612,000,000 JPY
197,900,000,000 JPY
204,989,000,000 JPY
Total assets
270,937,000,000 JPY
255,827,000,000 JPY
255,577,000,000 JPY
Basic earnings (loss) per share
100.28
203.64
259.63
87.99
187.52
Diluted earnings per share
259.59
Equity-to-asset ratio
0.791 xbrli:pure
0.773 xbrli:pure
0.801 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.